Private Equity and Dermatology: Acquisition Locations and Concentration
Eight years of consolidation activity has resulted in a wide spread of PE-backed practices across the United States.
Dermatology and Private Equity: Significant Potential Remains
Based on our detailed tracking and analysis, the dermatology market is only 11.5% consolidated as of this publication.
Gastroenterology Acquisitions Spread Across America
Two key factors provide a view of current and future consolidation speed.
List of Private Equity Firms Investing in Gastroenterology Practices and Surgery Centers
The number of private equity firms investing in gastroenterology practices and surgery centers doubled in 2019. As of the end of 2019, six PE firms were actively investing in the space with three new firms entering in the last three quarters of 2019.
List of Private Equity Firms Investing in Ophthalmology Practices and Surgery Centers
As of the end of 2019, there were 25 private equity firms actively investing in ophthalmology practices and surgery centers. It is among the most active physician practice consolidations currently taking place in the United States.
Ophthalmology and Private Equity: Key Findings / 2020 Outlook
Our recently published white paper examined all core aspects of private equity's investment in ophthalmology practices and surgery centers from 2012 – 2019.
White Paper: Private Equity Investment in Gastroenterology – 2020 Outlook
Is gastroenterology the next darling of private equity? Large GI practice acquisitions exploded in 2019, tripling that of the prior three years. Expansion to new geographic areas doubled in each of the last three quarters of 2019. We see this activity accelerating in 2020 when a significant number of new private equity investors enter the market and physician sellers see high demand for their practices.
White Paper: Private Equity Investment in Ophthalmology – 2020 Outlook
Private equity investment in ophthalmology practices has been one of the "hottest" sectors in M&A over the last several years. We believe the market will continue to be strong but our key indicators now signal a transition to Network Growth in 2020 – a more mature phase characterized by consistent add-on acquisitions. There are still open geographies with great opportunity, such as Texas and multiple areas on the West Coast. We project increased deal activity in these areas including large platform acquisitions.
The End Goal for Private Equity and Physician Sellers
Improved Patient Care, Revenue Growth, Profit Improvement
In order to gain a return on their investment, PE firms look to improve operations and grow their portfolio companies through organic and inorganic initiatives, ideally driving a much higher valuation and EBITDA multiple when the portfolio company is sold (usually in 5-7 years).
FOCUS Healthcare and Life Sciences Report: Summer 2019
Featured in this Issue The Instant, Custom, Connected Future of ...
